Lipocine Inc (LPCN)
4.79
+0.24
(+5.27%)
USD |
NASDAQ |
Apr 26, 16:00
4.79
0.00 (0.00%)
After-Hours: 16:45
Lipocine Price to Book Value: 1.250 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 1.187 |
| April 24, 2024 | 1.159 |
| April 23, 2024 | 1.253 |
| April 22, 2024 | 1.323 |
| April 19, 2024 | 1.375 |
| April 18, 2024 | 1.420 |
| April 17, 2024 | 1.388 |
| April 16, 2024 | 1.242 |
| April 15, 2024 | 1.398 |
| April 12, 2024 | 1.516 |
| April 11, 2024 | 1.673 |
| April 10, 2024 | 1.699 |
| April 09, 2024 | 1.506 |
| April 08, 2024 | 1.373 |
| April 05, 2024 | 1.253 |
| April 04, 2024 | 1.203 |
| April 03, 2024 | 1.287 |
| April 02, 2024 | 1.297 |
| April 01, 2024 | 1.383 |
| March 28, 2024 | 1.357 |
| March 27, 2024 | 1.338 |
| March 26, 2024 | 1.308 |
| March 25, 2024 | 1.148 |
| March 22, 2024 | 1.054 |
| March 21, 2024 | 1.073 |
| Date | Value |
|---|---|
| March 20, 2024 | 1.104 |
| March 19, 2024 | 1.112 |
| March 18, 2024 | 1.172 |
| March 15, 2024 | 1.200 |
| March 14, 2024 | 1.224 |
| March 13, 2024 | 1.25 |
| March 12, 2024 | 1.033 |
| March 11, 2024 | 0.9421 |
| March 08, 2024 | 0.9421 |
| March 07, 2024 | 0.9473 |
| March 06, 2024 | 0.9343 |
| March 05, 2024 | 0.9499 |
| March 04, 2024 | 0.9525 |
| March 01, 2024 | 0.9995 |
| February 29, 2024 | 0.9943 |
| February 28, 2024 | 1.013 |
| February 27, 2024 | 1.007 |
| February 26, 2024 | 1.007 |
| February 23, 2024 | 0.9943 |
| February 22, 2024 | 1.018 |
| February 21, 2024 | 1.031 |
| February 20, 2024 | 1.044 |
| February 16, 2024 | 1.046 |
| February 15, 2024 | 1.046 |
| February 14, 2024 | 1.067 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5269
Minimum
Sep 28 2023
12.07
Maximum
Feb 10 2021
3.300
Average
2.701
Median
Price to Book Value Benchmarks
| Alpine Immune Sciences Inc | 12.90 |
| Eliem Therapeutics Inc | 1.043 |
| NovaBay Pharmaceuticals Inc | 1.723 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.6668 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0435 |
| Price | 4.79 |
| Earnings Yield | -63.67% |
| Market Cap | 25.46M |
| PEGY Ratio | -0.0435 |